Pluta Cancer Center

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Ovarian cancer2 trials
• Triple-negative breast cancer2 trials
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Endometrial cancer1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Recruiting4 trials
• Active, not recruiting1 trial

Lead sponsor

• Alliance for Clinical Trials in Oncology1 trial
• National Cancer Institute (NCI)1 trial
• NRG Oncology1 trial
• SWOG Cancer Research Network1 trial
• University of Rochester1 trial

Running trials

• Recruiting

  LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  NCT06073431· University of Rochester· Source

  Contact: Po-Ju Lin (principal investigator)

• Recruiting

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  NCT05879926· Phase 3· NRG Oncology· Source

  Contact: Susan F. Dent (principal investigator)

• Recruiting

  Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

  NCT05929768· Phase 3· SWOG Cancer Research Network· Source

  Contact: Alissa J. Huston (principal investigator)

• Recruiting

  Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

  NCT05812807· Phase 3· Alliance for Clinical Trials in Oncology· Source

  Contact: Anna C. Weiss (principal investigator)

• Recruiting

  Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  NCT05564377· Phase 2· National Cancer Institute (NCI)· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Triple-negative breast cancer2 recruiting
• Colorectal cancer1 recruiting
• Lung cancer1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting